青蒿素及其衍生物的抗肿瘤作用研究进展
作者：何林;傅川;曾明辉;
Author：
收稿日期： 年卷（期）页码：2015,30(04):-517-520
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：青蒿素类药物;抗疟药;抗癌活性;分子机制;细胞增殖;细胞凋亡;细胞转移;新生血管生成
Key words：
基金项目：四川省卫生和计划生育委员会课题(项目编号:130547)
中文摘要
抗疟药青蒿素及其类似物具有较强的抗肿瘤活性,且毒性低。其抗肿瘤机制可能是抑制癌细胞增殖、转移和血管生成,促进细胞凋亡等。现查阅文献,从青蒿素及其衍生物的抗肿瘤效应、分子机制及未来发展的研究进展进行综述。
参考文献
[1]Huang XJ,Ma ZQ,Zhang WP,et al.Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1αactivation in C6 glioma cells[J].J Pharm Pharmacol,2007,59(6):849-856.
[2]姚丽,谢红,陈立军,等.利用基因芯片分析二氢青蒿素的抗肿瘤作用机制[J].中国中药杂志,2008,13:1583-1586.
[3]Jiao Y,Ge CM,Meng QH,et al.Dihydroartemisinin is an inhibitor of ovarian cancer cell growth[J].Acta Pharmacol Sinica,2007,28(7):1045-1056.
[4]GL Firestone,SN Sundar.Anticancer activities of artemisinin and its bioactive derivatives[J].Expert Rev Mol Med,2009,11:32.
[5]Chen H,Sun B,Pan S,et al.Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo[J].Anticancer Drugs,2009,20(2):131-140.
[6]Wang SJ,Gao Y,Chen H,et al.Dihydroartemisinin inactivates NF-κB and potentiates the antitumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo[J].Cancer Lett,2010,293(1):99-108.
[7]Willoughby JA,Sundar SN,Cheung M,et al.Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4(CDK4)promoter and inhibiting CDK4 gene expression[J].J Biolog Chem,2009,284(4):2203-2213.
[8]Youns M,Efferth T,Reichling J,et al.Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cellsp[J].Biochem Pharmacol,2009,78(3):273-283.
[9]Hamacher-Brady A,Stein HA,Turschner S,et al.Artesunate activates mitochondrial apoptosis in breast cancer cells via ironcatalyzed lysosomal reactive oxygen species production[J].J Biolog Chem,2011,286(8):6587-6601.
[10]Xu Q,Li ZX,Peng HQ,et al.Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo[J].Biomed Biotechnol,2011,12(4):247-255.
[11]Ji Y,Zhang YC,Pei LB,et al.Anti-tumor effects of dihydroartemisinin on human osteosarcoma[J].Mol Cell Biochem,2011,351(1-2):99-108.
[12]Lu JJ,Meng LH,UT Shankavaram,et al.Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells[J].Biochem Pharmacol,2010,80(1):22-30.
[13]CM Cabello,SD Lamore,WB Bair III,et al.The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis[J].Invest New Drugs,2012,30(4):1289-1301.
[14]Handrick R,Ontikatze T,Bauer KD,et al.Dihydroartemisinin induces apoptosis by a bak-dependent intrinsic pathway[J].Mol Cancer Ther,2010,9(9):2497-2510.
[15]He Q,Shi J,Shen XL,et al.Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells[J].Cancer Biol Ther,2010,9(10):817-823.
[16]Buommino E,Baroni A,Canozo N,et al.Artemisinin reduces human melanoma cell migration by down-regulatingαvβ3 integrin and reducing metalloproteinase 2 production[J].Invest New Drugs,2008,27(5):412-418.
[17]Weifeng T,Feng S,Xiangji L,et al.Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells[J].Phytomedicine,2011,18(2-3):158-162.
[18]Hwang YP,Yun HJ,Kim HG,et al.Suppression of PMAinduced tumor cell invasion by dihydroartemisinin via inhibition of PKCα/Raf/MAPKs and NF-κB/AP-1-dependent mechanisms[J].Biochem Pharmacol,2010,79(12):1714-1726.
[19]Wang J,Zhang B,Guo Y,et al.Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C[J].Pharmacol,2008,82(2):148-155.
[20]Chen HH,Zhou HJ,Wang WQ,et al.Antimalarial dihydroartemisinin also inhibits angiogenesis[J].Cancer Chemother Pharmacol,2004,53(5):423-432.
[21]Anfosso L,Efferth T,Albini A,et al.Microarray expression profiles of angiogenesis related genes predict tumor cell response to artemisinins[J].Pharmacogenomics J,2006,6(4):269-278.
[22]Zhou HJ,Zhang JL,Li A,et al.Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro[J].Cancer Chemother Pharmacol,2010,66(1):21-29.
[23]Wang SJ,Sun B,Cheng ZX,et al.Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κBpathway[J].Cancer Chemother Pharmacol,2011,68(6):1421-1430.
[24]Mercer AE,Copple IM,Maggs JL,et al.The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials[J].J Biolog Chem,2011,283(2):987-996.
[25]Huang XJ,Ma ZQ,Zhang WP,et al.Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1αactivation in C6 glioma cells[J].J Pharm Pharmacol,2007,59(6):849-856.
[26]Michaelis M,Kleinschmidt MC,Barth S,et al.Anticancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines[J].Biochem Pharmacol,2010,79(2):130-136.
[27]LH Stockwin,Han B,Yu SX,et al.Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction[J].Int J Cancer,2009,125(6):1266-1275.
[28]Liu Y,CN Lok,BCB Ko,et al.Subcellular localization of a fluorescent artemisinin derivative to endoplasmic reticulum[J].Org Lett,2010,12(7):1420-1423.
【关闭】
